MEDIROM Healthcare Technologies, Inc. · NASDAQ:MRM

MEDIROM Healthcare Technologies, Inc. financial statements

MEDIROM Healthcare Technologies, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in JPY

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Revenue6.23B8.30B6.83B6.95B5.41B3.34B3.91B3.43B
Cost of revenue137.8K6.05B5.26B5.05B3.99B2.91B2.96B2.48B
Gross profit3.90M2.25B1.57B1.90B1.42B428.9M950.8M956.9M
Research and development13.5M
Selling, general and administrative2.57B2.24B1.96B1.81B1.82B1.07B871.9M771.6M
Operating income-3.39B-18.1M-391.6M97.0M-470.6M-746.1M34.4M73.3M
Depreciation and amortization532.7M290.0M252.6M184.1M126.2M62.3M46.2M44.3M
EBITDA-2.86B271.9M-139.0M281.0M-344.3M-683.8M80.5M117.5M
Interest expense66.2M49.7M36.9M9.80M11.9M13.2M13.6M15.5M
Income before tax-3.34B47.7M20.6M179.8M-414.5M-626.7M32.7M91.6M
Income tax304.1M-90.5M-94.4M30.8M576.3M-87.5M16.0M25.3M
Net income-3.63B148.8M115.4M149.0M-990.7M-539.2M17.3M66.3M
Earnings per share, basic-459.9229.1323.6430.54-203.13-133.974.6314.04
Earnings per share, diluted-459.9228.5222.3427.23-203.13-133.974.06

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash and equivalents92.0M329.4M106.3M605.5M370.6M1.44B513.6M211.7M
Short-term investments6.16M6.16M26.5M26.5M26.5M32.5M38.5M33.0M
Receivables671.7M1.36B621.9M534.7M312.3M148.5M337.0M283.0M
Inventory156.6M151.6M140.0M114.1M18.7M7.96M5.51M6.40M
Current assets1.49B2.71B1.76B2.36B1.38B2.09B1.38B934.0M
Property, plant and equipment154.6M435.7M451.5M424.3M425.0M235.9M169.0M2.27B
Goodwill0389.1M484.6M539.5M600.3M150.7M78.3M64.0M
Total assets4.68B8.09B6.85B6.75B5.75B5.71B4.76B4.52B
Accounts payable1.04B1.01B137.7M207.6M230.9M67.0M122.6M141.3M
Current liabilities4.73B4.18B3.56B3.64B3.20B2.65B2.26B2.35B
Long-term debt800.0M764.2M1.05B1.15B746.6M668.4M150.5M342.8M
Total debt1.60B1.88B1.55B1.25B908.8M910.7M342.1M2.85B
Total liabilities7.11B6.90B6.63B6.81B5.96B5.22B4.16B4.64B
Shareholders' equity-2.67B933.3M210.9M-59.4M-208.3M491.3M600.1M-117.6M
Shares outstanding7.90M2.02K7.90M7.90M4.88M4.88M4.88M4.72M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018
Cash from operations-1.16B-1.33B-631.7M-685.7M-557.2M-366.4M7.87M141.9M
Capital spending-10.3M-71.4M-135.8M-120.7M-95.7M-73.6M-7.41M-34.3M
Free cash flow-1.17B-1.40B-767.6M-806.4M-652.9M-440.0M464.0K107.6M
Cash from investing-22.5M361.4M-328.6M580.4M-83.9M-139.6M-37.9M-79.4M
Cash from financing940.0M1.19B461.2M340.1M-427.9M1.43B332.0M-74.5M
Change in cash-237.4M223.1M-499.1M234.8M-1.07B926.1M301.9M-12.0M